Standard InChI: InChI=1S/C10H11N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h1-4,6-7,10,17-18H,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1
Standard InChI Key: CWNMDMYGRVHXDR-KQYNXXCUSA-N
Associated Targets(Human)
Adenosylhomocysteinase 906 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
MOLT-4 49676 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
CCRF-CEM 65223 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
E6SM 1586 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
HEL 6614 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Associated Targets(non-human)
L1210 27553 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
FM3A 1296 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Human alphaherpesvirus 1 11089 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Human alphaherpesvirus 2 4932 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Human betaherpesvirus 5 5122 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Vaccinia virus 4609 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Vero 26788 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Adenosylhomocysteinase 70 Activities
Activity Type
Relation
Activity value
Units
Action Type
Journal
PubMed Id
doi
Assay Aladdin ID
Molecule Features
Natural Product: Yes
Oral: No
Chemical Probe: No
Parenteral: No
Molecule Type: Small molecule
Topical: No
First In Class: No
Black Box: No
Chirality: No
Availability: No
Prodrug: No
Drug Indications
MESH ID
MESH Heading
EFO IDs
EFO Terms
Max Phase for Indication
References
Mechanisms of Action
Mechanism of Action
Action Type
target ID
Target Name
Target Type
Target Organism
Binding Site Name
References
Properties
Molecular Weight: 265.23
Molecular Weight (Monoisotopic): 265.0811
AlogP: -1.77
#Rotatable Bonds: 2
Polar Surface Area: 136.38
Molecular Species: NEUTRAL
HBA: 9
HBD: 3
#RO5 Violations: 0
HBA (Lipinski): 9
HBD (Lipinski): 4
#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.42
CX Basic pKa: 3.94
CX LogP: -1.93
CX LogD: -1.93
Aromatic Rings: 2
Heavy Atoms: 19
QED Weighted: 0.54
Np Likeness Score: 1.04
References
1.Wnuk SF, Yuan CS, Borchardt RT, Balzarini J, De Clercq E, Robins MJ.. (1997) Anticancer and antiviral effects and inactivation of S-adenosyl-L-homocysteine hydrolase with 5'-carboxaldehydes and oximes synthesized from adenosine and sugar-modified analogues., 40 (11):[PMID:9171871][10.1021/jm960828p]
2.Liu S, Yuan CS, Borchardt RT.. (1996) Aristeromycin-5'-carboxaldehyde: a potent inhibitor of S-adenosyl-L-homocysteine hydrolase., 39 (12):[PMID:8691429][10.1021/jm950916u]
3.Wnuk SF, Liu S, Yuan CS, Borchardt RT, Robins MJ.. (1996) Inactivation of S-adenosyl-L-homocysteine hydrolase by amide and ester derivatives of adenosine-5'-carboxylic acid., 39 (21):[PMID:8863793][10.1021/jm960313y]
4.Liu S, Wnuk SF, Yuan C, Robins MJ, Borchardt RT.. (1993) Adenosine-5'-carboxaldehyde: a potent inhibitor of S-adenosyl-L-homocysteine hydrolase., 36 (7):[PMID:8464042][10.1021/jm00059a013]
5.Helguera AM, Rodríguez-Borges JE, García-Mera X, Fernández F, Cordeiro MN.. (2007) Probing the anticancer activity of nucleoside analogues: a QSAR model approach using an internally consistent training set., 50 (7):[PMID:17341060][10.1021/jm061445m]